Jade Biosciences Ownership | Who Owns Jade Biosciences?
Jade Biosciences Ownership Summary
Jade Biosciences is owned by 40.23% institutional investors, 1.12% insiders, and 58.65% retail investors. Fmr is the largest institutional shareholder, holding 15.80% of JBIO shares. Polar Capital Biotech S Inc is the top mutual fund, with 2.87% of its assets in Jade Biosciences shares.
JBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jade Biosciences | 40.23% | 1.12% | 58.65% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 9.13M | 15.80% | $202.80M |
| Janus henderson group | 3.11M | 9.90% | $43.56M |
| Fairmount funds management | 4.55M | 7.88% | $101.18M |
| Ra capital management | 3.67M | 6.35% | $81.57M |
| Vr adviser | 3.22M | 5.57% | $71.56M |
| Vanguard group | 2.10M | 5.29% | $32.34M |
| Bellevue group | 3.06M | 5.29% | $67.95M |
| Paradigm biocapital advisors lp | 2.86M | 4.95% | $63.49M |
| Blackrock funding, inc. /de | 2.80M | 4.85% | $62.25M |
| Franklin resources | 2.79M | 4.83% | $62.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 991.78K | 13.55% | $22.04M |
| Fairmount funds management | 4.55M | 6.69% | $101.18M |
| Avidity partners management lp | 1.70M | 6.05% | $37.79M |
| Acorn capital advisors | 986.76K | 5.98% | $21.93M |
| Foresite capital management vi | 886.67K | 3.07% | $19.70M |
| Vr adviser | 3.22M | 2.17% | $71.56M |
| Bellevue group | 3.06M | 1.43% | $67.95M |
| Samsara biocapital | 736.24K | 1.34% | $16.36M |
| Verdad advisers, lp | 56.38K | 1.20% | $1.25M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | $63.49M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M |
| Franklin resources | 2.79M | 0.01% | 2.79M |
| Fmr | 9.13M | 0.01% | 2.04M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -2.28M |
| Frazier life sciences management | - | - | -1.41M |
| Great point partners | - | - | -964.46K |
| Driehaus capital management | - | - | -635.50K |
| Rtw investments, lp | - | - | -573.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 3.11M | 0.02% | 3.11M | $43.56M |
| Paradigm biocapital advisors lp | 2.86M | 1.19% | 2.86M | $63.49M |
| Franklin resources | 2.79M | 0.01% | 2.79M | $62.04M |
| Adage capital partners gp | 1.91M | 0.06% | 1.91M | $42.46M |
| Polar capital | 1.85M | 0.10% | 1.85M | $41.04M |
Sold Out
| Holder | Change |
|---|---|
| Root financial partners | -1.00 |
| Principal securities | -5.00 |
| Mai capital management | -6.00 |
| Glenmede investment management, lp | -53.00 |
| Simplex trading | -83.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 62 | -41.51% | 12,616,762 | -73.20% | 40 | 0.28% | 32 | -59.49% | 21 | 61.54% |
| Dec 31, 2025 | 75 | -1.32% | 20,804,363 | -34.20% | 52 | 0.82% | 55 | 77.42% | 10 | -54.55% |
| Sep 30, 2025 | 29 | -59.15% | 6,448,004 | -79.55% | 22 | 0.18% | 9 | -87.14% | 14 | - |
| Jun 30, 2025 | 32 | - | 6,707,208 | - | 134,144 | - | 32 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Biotech S Inc | 1.75M | 2.87% | 734.32K |
| Vanguard Total Stock Mkt Idx Inv | 1.70M | 2.79% | 284.01K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.70M | 2.79% | 284.01K |
| Fidelity Growth Compy Commingled Pl S | 1.63M | 2.67% | 242.10K |
| State Street® SPDR® S&P® Biotech ETF | 1.51M | 2.48% | 3.47K |
| Fidelity Growth Company Fund | 1.19M | 1.96% | 181.93K |
| Janus Henderson Hrzn Biotec E2 USD | 963.35K | 1.58% | 215.85K |
| iShares Russell 2000 ETF | 833.59K | 1.37% | -14.78K |
| Franklin Biotechnology Discv A(acc)USD | 827.70K | 1.36% | 571.09K |
| Fidelity Select Health Care | 819.58K | 1.35% | 179.58K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Frohlich Tom | Chief Executive Officer | Buy | $44.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
JBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools